383
We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound reduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of rosiglitazone therapy.
 three patients: Subject; three: Subject.Population; profound reduction in plasma HDL cholesterol and apolipoprotein AI levels: Effect; rosiglitazone therapy: Treatment; rosiglitazone: Treatment.Drug; soon after: Treatment.Time_elapsed; preexisting diabetic dyslipidemia: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 three patients: Subject; three: Subject.Population; profound reduction in plasma HDL cholesterol and apolipoprotein AI levels: Effect; rosiglitazone therapy: Treatment; rosiglitazone: Treatment.Drug; soon after: Treatment.Time_elapsed; preexisting diabetic dyslipidemia: Treatment.Disorder